Geropharmacology: A primer for advanced practice acute care and critical care nurses, part II

AACN Advanced Critical Care

Volumn 19, Issue 2, 2008, Pages 134-149

  Ferrario, Catherine G ^a  

^a UNIVERSITY OF ST FRANCIS   (United States)

Author keywords

Advanced practice nurses; Geriatric pharmacology; Life threatening outcomes; Potentially inappropriate drug classifications; Potentially inappropriate medications

Indexed keywords

ACUTE DISEASE; AGED; ARTICLE; CONTINUING EDUCATION; DRUG THERAPY; GERIATRIC NURSING; HUMAN; INTENSIVE CARE; MANPOWER; MEDICATION ERROR; PHARMACOLOGY;

ACUTE DISEASE; AGED; CRITICAL CARE; DRUG THERAPY; EDUCATION, CONTINUING; GERIATRIC NURSING; HUMANS; MEDICATION ERRORS; PHARMACOLOGY;

EID: 48549092345     PISSN: 15597768     EISSN: 15597768     Source Type: Journal    
DOI: 10.1097/01.AACN.0000318115.74685.5e     Document Type: Article

References (59)

1. Hilmer SN, Mager DE, Simonsick EM, et al. A Drug Burden Index to define the functional burden of medications on older people. Arch Intern Med. 2007;167:781-787.
2. McLean AJ, Le Couteur DG. Aging biology and geriatric clinical pharmacology. Pharmacol Rev. 2004;56: 163-184.
3. Nagappan R, Parkin G. Geriatric critical care. Crit Care Clin. 2003;19(2):253-270.
4. Barry PJ, O'Keefe N, O'Connor KA, O'Mahony D. Inappropriate prescribing in the elderly: A comparison of the Beers criteria and the Improved Prescribing in the Elderly Tool (IPET) in acutely ill elderly hospitalized patients. J Clin Pharm Ther. 2006;31:617-626.
5. Egger SS, Bachmann A, Hubmann N, Schlienger RG, Krahenbuhl S. Prevalence of potentially inappropriate medication use in elderly patients: Comparison between general medical and geriatric wards. Drugs Aging. 2006;23(10):823-837.
6. Steinman MA, Rosenthal GE, Landefeld CS, Bertenthal D, Sen S, Kaboli PJ. Conflicts and concordance between measures of medication prescribing quality. Med Care. 2007;45(1): 95-99.
7. van der Hooft CS, Jong GW, Dieleman JP, et al. Inappropriate drug prescribing in older adults: The updated 2002 Beers criteria-a population-based cohort study. Br J Clin Pharmacol. 2005;60:2:137-144.
8. Nielson C. Pharmacologic considerations in critical care of the elderly. Clin Geriatr Med. 1994;10(1):71-89.
9. Fick DM, Cooper JW, Wade WE, Waller JL, Maclean R, Beers MH. Updating the Beers criteria for potentially inappropriate medication use in older adults. Arch Intern Med. 2003;163:2716-2724.
10. Grajeda-Higley L. Understanding Pharmacology: A Physiologic Approach. Stamford, CT: Appleton & Lange; 2000.
11. Knight EL, Avorn J. Quality indicators for appropriate medication use in vulnerable elders. Ann Intern Med. 2001;135(8):703-710.
12. Grasso BC, Clary CM, Evans SJ, et al. Medication errors in psychiatric care: Incidence and reduction strategies CME/CE. http://www.medscape.com/ viewprogram/7319. Accessed July 11, 2007.
13. Ferrario CG. Geropharmacology: A primer for advanced practice acute care and critical care nurses; part I. AACN Adv Crit Care. 2008;19(1):23-35.
14. Bressler R, Bahl JJ. Principles of drug therapy for the elderly patient. Mayo Clin Proc. 2003;78:1564-1577.
15. Miller S. Geriatric drug therapy. In: Herfindal ET, Gourley DR, eds. Textbook of Therapeutics: Drug and Disease Management. 7th ed. Philadelphia: Lippincott Williams & Wilkins; 2000:2063-2076.
16. Eames D, Haffey WJ, Cope DV. Treatment of behavioral disorders. In: Rosenthal M, Bond MR, Miller JD, Griffith ER, eds. Rehabilitation of the Adult and Child With Traumatic Brain Injury. 2nd ed. Philadelphia: FA Davis; 1990:410-432.
17. Fulmer T, Foreman MD, Zwicker D. Medication in older adults. In: Mezey M, Fulmer T, Abraham I, eds. Geriatric Nursing Protocols for Best Practice. 2nd ed. New York: Springer; 2003:207-228.
18. Mesulam M-M. Principles of Behavioral Neurology. Philadelphia: FA Davis; 1985.
19. Nelson JE, Tandon N, Mercado AF, Camhi SL, Ely W, Morrison RS. Brain dysfunction: Another burden of the chronically critically ill. Arch Intern Med. 2006;166:1993-1999.
20. Salzman C. Clinical Geriatric Psychopharmacology. Baltimore: Williams & Wilkins; 1998.
21. Tabloski PA. Gerontological Nursing. Upper Saddle River, NJ: Pearson Prentice-Hall; 2006.
22. Marik PE. Management of the critical ill geriatric patient. Crit Care Med. 2006;34(suppl):S176-S182.
23. Moore LA, Blount KA. Medications and the elderly in the critical care setting. Crit Care Nurs Clin North Am. 2002;14:111-119.
24. Maynard CK. Differentiate depression from dementia. Nurse Pract. 2003;28:18-27.
25. Mick DJ, Ackerman MH. Critical care nursing for older adults: Pathophysiological and functional considerations. Nurs Clin North Am. 2004;39:473-493.
26. Fortinash KM, Holoday-Worrett PA. Psychiatric Mental Health Nursing. 2nd ed. St Louis, MO: Mosby; 2000.
27. Salzman C. Psychiatric Medications for Older Adults: The Concise Guide. New York: Guilford Press; 2001.
28. Perry EK, Kilford L, Lees AJ, Burn DJ, Perry RH. Increased Alzheimer pathology in Parkinson's disease related to antimuscarinic drugs. Ann Neurol. 2003;54:235-238.
29. Inouye SK. Prevention of delirium in hospitalized older patients. Risk factors and targeted intervention strategies. Ann Med. 2000;32:257-263.
30. Sunderland T. Neurotransmission in the aging central nervous system. In: Salzman C, ed. Clinical Geriatric Psychopharmacology. Baltimore: Williams & Wilkins; 1998:51-69.
31. Lebowitz BD, Pearson JL, Cohen GD. Older Americans and their illnesses. In Salzman C, ed. Clinical Geriatric Psychopharmacology. 3rd ed. Baltimore: Williams & Wilkins; 1998:3-20.
32. Youngkin EQ, Sawin KB, Kissinger JF, Israel DS. Pharmacotherapeutics: A Primary Care Clinical Guide. 2nd ed. Upper Saddle River, NJ: Prentice-Hall; 2004.
33. Laroche M-L, Charmes J-P, Nouaille Y, Fourrier A, Merle L. Impact of hospitalisation in an acute medical geriatric unit on potentially inappropriate medication use. Drugs Aging. 2006;23(1):49-59.
34. Ellul J, Archer N, Foy CM, et al. The effects of commonly prescribed drugs in patients with Alzheimer's disease on the rate of deterioration. J Neurol Neurosurg Psychiatry. 2007;78:233-239.
35. Katzung BG. Special aspects of geriatric pharmacology. In: Katzung BG, ed. Basic & Clinical Pharmacology. 9th ed. New York: Lange Medical Books/McGraw-Hill; 2004:1007-1014.
36. Peterson JF, Kuperman GJ, Shek C, Patel M, Avorn J, Bates DW. Guided prescription of psychotropic medications for geriatric inpatients. Arch Intern Med. 2005;165:802-807.
37. Schulberg HC, Katon W, Shear KS. Management of mood and anxiety disorders in primary care. In: Rush AJ, ed. Mood & Anxiety Disorders. Baltimore: Williams & Wilkins; 1998:198-223.
38. Dombrovski AY, Szanto K. Prevention of suicide in the elderly. Ann Long-Term Care. 2005;13:25-32.
39. Cronin-Stubbs D, Mendes de Leon CF, Beckett LA, Field RS, Glynn RJ, Evans DA. Six-year effect of depressive symptoms on the course of physical disability in community-living older adults. Arch Intern Med. 2000;160: 3074-3080.
40. Rayner A. Managing psychotic symptoms in the older patient. Geriatrics Aging. 2007;10(4):241-245. http://www.medscape.com/viewarticle/556036. Accessed May 23, 2007. (Pubitemid 46709337)
41. Jeste DV, Eastham JH, Lohr JB, Salzman C. Diagnosis of disordered behavior and psychosis. In: Salzman C, ed. Clinical Geriatric Psychopharmacology. 3rd ed. Baltimore: Williams & Wilkins; 1998:97-105.
42. Taft LB, Cronin-Stubbs D. Behavioral symptoms in dementia: An update. Res Nurs Health. 1995;18: 143-163.
43. Cronin-Stubbs D. Interventions for cognitive impairment and neurobehavioral disturbances of older adults: A research synthesis. Ann Rev Nurs Res. 1997;15:35-56.
44. Pryor J. What do nurses do in response to their predictions of aggression? J Neurosci Nurs. 2006;38(3):177-182. http://www.medscape.com/ viewarticle/548017. Accessed June 21, 2007.
45. Skrobik YK, Bergeron N, Dumont M, et al. Olanzapine vs haloperidol: Treating delirium in a critical care setting. Intensive Care Med. 2004;30:444-449.
46. National Institutes of Health. Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. 7th Report of the Joint National Committee. Bethesda, MD: National Institutes of Health, US Department of Health and Human Services; 2003. NIH Publication No. 035233.
47. Hahn KL, Shapiro KB. Highlights of the American Pharmacists Association 2007 annual meeting. http://www.medscape.com/viewprogram/7099. Accessed May 23, 2007.
48. Fisher AA, Le Couteur DG. Nephrotoxicity and hepatotoxicity of histamine H2 receptor antagonists. Drug Saf. 2001;24(1):39-57.
49. Arcangelo BP, Peterson AM. Pharmacotherapeutics for Advanced Practice: A Practical Approach. Philadelphia: Lippincott; 2001.
50. Briggs G. Geriatric issues. In: Youngkin EQ, Sawin KJ, Kissinger JF, Israel DS, eds. Pharmacotherapeutics: A Primary Care Clinical Guide. Stamford, CT: Appleton & Lange; 1999:199-204.
51. McKenry LM, Salerno E. Mosby's Pharmacology in Nursing. 21st ed. St Louis, MO: CV Mosby; 2003.
52. Moore I, Sayer JA, Nayar A, Ahmed S, Tapson JS. Pantoprazole-induced acute interstitial nephritis. J Nephrol. 2004;17:580-582.
53. Gaba DM. Anesthesiology as a model for patient safety in health care. BMJ. 2000;320:785-788.
54. Institute of Medicine. Crossing the Quality Chasm: A New Health System for the 21st Century. Washington, DC: National Academies Press; 2001.
55. Rothschild JM, Landrigan CP, Cronin JW, et al. The Critical Care Safety Study: The incidence and nature of adverse events and serious medical errors in intensive care. Crit Care Med. 2005;33(8);1694-1700.
56. World Health Organization. WHO Collaborating Centre for Patient Safety Releases Nine Life-Saving Patient Safety Solutions. http://www. jointcommissioninternational.org/solutions. Accessed May 2, 2007.
57. Ball K, Berch DB, Helmers KF, et al. Effects of cognitive training interventions with older adults: A randomized controlled trial. JAMA. 2003;288:2271-2281.
58. Albert NM. Evidence-based nursing care for patients with heart failure. AACN Adv Crit Care 2006;17(2):170-185.
59. Brenner GM, Stevens CW. Pharmacology. 2nd ed. Philadelphia: Saunders; 2006.